SavedAdd your journal

Journals / Medical Science and Discovery / 2019 / Cilt: 6 Sayı: 8

Evaluation and treatment of the eosinophilic lung diseases in 7 patients

Tugce UZAR
Gozde DUYU
Ahmet DİRİCAN
Selda GUNAYDİN
Nazli TOPBASİ
Hulya BAYİZ
Şevket ÖZKAYA
Pages
150–159
Publication Date
2019-08-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Systemic corticosteroids are provided rapid control not only in symptoms but also radiological and clinical improvement of ELD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Eosinophilic lung diseases (ELD) are a rare group of heterogeneous diseases characterized by the increase of the eosinophilic ratio in the airways and lung parenchyma.
📊
Key Findings & Data:Conclusion: Peripheral eosinophilia with pulmonary infiltrates is diagnostic clues of eosinophilic lung diseases.
💡
Conclusion & Impact:Systemic corticosteroids are provided rapid control not only in symptoms but also radiological and clinical improvement of ELD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:eosinophilic lung diseases · acute eosinophilic pneumonia · chronic eosinophilic pneumonia

Abstract

Objective: Eosinophilic lung diseases (ELD) are a rare group of heterogeneous diseases characterized by the increase of the eosinophilic ratio in the airways and lung parenchyma. We aimed to present and discuss the clinical, radiologic and pathologic features of six patients with eosinophilic lung diseases. Conclusion: Peripheral eosinophilia with pulmonary infiltrates is diagnostic clues of eosinophilic lung diseases. Systemic corticosteroids are provided rapid control not only in symptoms but also radiological and clinical improvement of ELD.

🔖

Cite This Article

UZAR, T., DUYU, G., DİRİCAN, A., GUNAYDİN, S., TOPBASİ, N., BAYİZ, H., ÖZKAYA, Ş. (2019). Evaluation and treatment of the eosinophilic lung diseases in 7 patients. Medical Science and Discovery, Cilt: 6 Sayı: 8, 150–159. https://ajindex.com/articles/1002957

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Aouadi S, Melki B, Braham E, et al. Eosinophilic lung disease. Eur Respir J 2016; 48
  2. Jeong YJ, Kim K, Seo IJ, et al. Eosinophilic Lung Diseases: A Clinical, Radiologic, and Pathologic Overview. RadioGraphics 2007; 27:617– 639
  3. Bernheim A, McLoud T. A Review of Clnical and Imaging Findings in Eosinophilic Lung Diseases. Am J of Roentgen. 2017;208: 1002-1010
  4. Marchand E, Etienne-Mastroianni B, Chanez P, et al. Idiopathic chronic eosinophilic pneumonia and asthma: how do they influence each other? Eur Respir J 2003; 22:8
  5. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994;150:1423–1438
  6. Johkoh T, Muller NL, Akira M, et al. Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients. Radiology 2000;216:773–780
  7. Campos LE, Pereira LF. Pulmonary eosinophilia. J Bras Pneumol 35: 561-573, 2009
  8. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med 27(2): 192-197, 2006
  9. Rizos E, Tsigkaropoulou E, Lambrou P. Risperidone-induced Acute Eosinophilic Pneumonia. In Vivo 2013;27 (5): 651-653
  10. Mann B. Eosinophilic lung disease. Clinical medicine. Circulatory, respiratory and pulmonary medicine. 2008 Jan;2:CCRPM-S575.